References
- 1. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns, GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990; 34:774-8.
- 2. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994; 84: 3071-9.
- 3. Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T, et al. Wilms’ tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998; 91:2969-76.
- 4. Chen Z. The possible role and application of WT1 in human leukemia. Int J Hematol. 2001; 73:39-46.10.1007/BF02981901
- 5. Algar E, Khromykh T, Smith S, Blackburn D, Bryson G, Smith P. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene. 1996; 12:1005-14.
- 6. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, et al. Growth inhibition of human leukemic cells by WT1 (Wilms’ tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 1996; 87:2878-84.
- 7. Smith SI, Down M, Boyd AW, Li CL. Expression of the Wilms’ tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice. Cancer Res. 2000; 60:808-14.
- 8. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al. Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumor despite tumor specific promoter methylation. Cancer Res. 2001; 61: 921-5.
- 9. Navakanit R, Graidist P, Leeanansaksiri W, Dechsukum C. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilm tumor 1 gene. J Med Assoc Thai. 2007; 90:2416-21.
- 10. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms’ tumor gene WT1. Proc Natl Acad Sci USA. 1991; 88:9618-22.
- 11. Yang L, Han Y, Saurez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007; 21:868-76.
- 12. Wang ZY, Qiu QQ, Deuel TF. The Wilms’ tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem. 1993; 268:9172-5.
- 13. Dechsukhum C, Ware JL, Ferreira-Gonalez A, Wilkinson DS, Garrett CT. Detection of novel truncated WT1 transcription in human neoplasia. Mol Diag. 2000; 5: 1-12.
- 14. Loeb DM. WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle. 2006; 5:1249-53.
- 15. Ito K, Oji Y, Tatsumi N, Shimizu S, Kanai Y, Nakazawa T, et al. Antiapoptotic function of 17AA(+)WT1 (Wilms’ tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene. 2006; 25:4217-29.
- 16. Burwell EA, McCarty GP, Simpson LA, Thompson KA, Loeb DM. Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene. 2007; 26:3423-30.
- 17. Simpson LA, Burwell EA, Thompson KA, Shahnaz S, Chen AR, Loeb DM. The antiapoptotic gene A1/BEFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy. Blood. 2006; 107:4695-702.
- 18. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 2000; 407:642-5.
- 19. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez- Guisa JM, Madden SL, Rauscher FJ, et al. DNA recognition by splicing variant of the Wilms’ tumor suppressor, WT1. Mol Cell Biol. 1994; 14:3800-9.
- 20. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. WT1 induces expression of insulin-like growth factor 2 in Wilms’ tumor cells. Cancer Res. 1995; 55:4540-3.
- 21. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, et al. RNA binding by the Wilms’ tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA. 1996; 93:7562-6.10.1073/pnas.93.15.7562
- 22. Hohenstein P, Hastie DN. The many facets of the Wilms’ tumour gene, WT1. Hum Mol Genet. 2006; 2: R196-201.10.1093/hmg/ddl196
- 23. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, et al. Wilms’ tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci. 2006; 97: 259-70.
- 24. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al. Expression of the Wilm’s tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res. 1999; 90:194-204.
- 25. Tatsumi N, Oji Y, Tsuji N, Tsuda A, Higashio M, Aoyagi S, et al. Wilms’ tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. Int J Oncol. 2008; 32:701-11.